Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride

References

• Soni K. Fluoroquinolones: chemistry and action: a review. Indo Global J Pharm Sci 2012;2:43–53.
   Google Scholar
• Komori C, Okada K, Kawamura K, et al. Sonodynamic effects of lomefloxacin derivatives conjugated with methoxy polyethylene glycol on S sarcoma 180 cells. Anticancer Res 2009;29:243–248.
   PubMed Web of Science ®Google Scholar
• Mishra GP, Bagui M, Tamboli V, Mitra AK. Recent applications of liposomes in ophthalmic drug delivery. J Drug Deliv 2011;2011:863734.
   PubMedGoogle Scholar
• Rathore KS, Nema RK. Review on ocular inserts. Int J PharmTech Res 2009;1:164–169.
   Google Scholar
• Abdelbary A, Salem HF, Khallaf RA, Ali AMA. Modeling, optimization and in-vitro corneal permeation of chitosan-lomefloxacin HCl nanosuspension intended for ophthalmic delivery. J Pharm Innov 2015;10:254–268.
   Web of Science ®Google Scholar
• Attama AA, Reichl S, Müller-Goymann CC. Sustained release and permeation of timolol from surface modified solid lipid nanoparticles through bioengineered human cornea. Curr Eye Res 2009;34:698–706.
   PubMed Web of Science ®Google Scholar
• Attama AA, Reichl S, Müller-Goymann CC. Diclofenac sodium delivery to the eye: in-vitro evaluation of novel solid lipid nanoparticles formulation using human cornea construct. Int J Pharm 2008;355:307–313.
   PubMed Web of Science ®Google Scholar
• Gannu PK, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery: an overview. Acta Pharm Sin B 2011;1:208–219.
   Google Scholar
• Okore VC, Attama AA, Ofokansi KC, et al. Formulation and evaluation of niosomes. Indian J Pharm Sci 2011;73:323–328.
   PubMed Web of Science ®Google Scholar
• Sahoo RK, Biswas N, Guha A, et al. Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives. BioMed Res Int 2014;2014:263604.
   PubMed Web of Science ®Google Scholar
• Carafa M, Santucci E, Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: characterization and in-vitro permeation studies. Int J Pharm 2002;231:21–32.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Ismail S, Kamal A, Alany RG. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci 2011;100:1833–1846.
   PubMed Web of Science ®Google Scholar
• Gaafar PME, Abdallah OY, Farid RM, Abdelkader H. Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone. J Liposome Res 2014;24:204–215.
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Garg A, Kaur IP. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. J Pharm Pharmacol 2004;56:1509–1517.
   PubMed Web of Science ®Google Scholar
• Azeem A, Ahmed FJ, Khan ZI, Talegaokar S. Nonionic surfactant vesicles as a carrier for transdermal delivery of frusemide. J Dispers Sci Technol 2008;29:723–730.
   Web of Science ®Google Scholar
• Abbas P, Jaleh V, Abdolhossein R. In-vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 2007;328:130–141.
   PubMed Web of Science ®Google Scholar
• Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech 2010;11:1119–1127.
   PubMed Web of Science ®Google Scholar
• Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech 2008;9:740–747.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhao F, Lin N, et al. Studies on a high encapsulation of colchicine by niosome system. Int J Pharm 2002;244:73–80.
   PubMed Web of Science ®Google Scholar
• Junyaprasert V B, Teeranachaideekul V, Supaperm T. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech 2008;9:851–859.
   PubMed Web of Science ®Google Scholar
• Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 2009;360:156–163.
   Web of Science ®Google Scholar
• Rangasamy S, Ayyasamy B, Raju S, et al. Formulation and in vivo evaluation of niosomes encapsulated acyclovir. J Pharm Res 2008;1:163–166.
   Google Scholar
• Gupta AK, Madan S, Majumdar DK, Maitra A. Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies. Int J Pharm 2000;209:1–14.
   PubMed Web of Science ®Google Scholar
• Kahlmeter G, Brown DF, Goldstein FW. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 2003;52:145–148.
   PubMed Web of Science ®Google Scholar
• Gianasi E, Cociancich F, Uchegbu IF, et al. Pharmaceutical and biological characterization of a doxorubicin-polymer conjugate (PK1) entrapped in sorbitan monostearate Span 60 niosomes. Int J Pharm 1997;148:139–148.
   Web of Science ®Google Scholar
• Rathore MS, Majumdar DK. Effect of formulation factors on in-vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS PharmSciTech 2006;7:1–6.
   PubMed Web of Science ®Google Scholar
• Abul Kalam M, Sultana Y, Ali A, et al. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. J Drug Target 2010;18:191–204.
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, et al. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J Drug Target 2011;19:409–417.
   PubMed Web of Science ®Google Scholar
• Viertler C, Groelz D, Gündisch S, et al. A new technology for stabilization of biomolecules in tissues for combined histological and molecular analyses. J Mol Diag 2012;14:458–466.
   PubMed Web of Science ®Google Scholar
• Sankhayan A, Pawar P. Recent trends in niosome as vesicular drug delivery system. J Appl Pharm Sci 2012;2:20–32.
   Google Scholar
• Ranga PM, Natarajan R, Rajendran NN. Formulation and evaluation of zidovudine loaded niosomes. J Pharm Nanotechnol 2013;1:12–18.
   Google Scholar
• Chen Y, Lu Y, Chen J, et al. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm 2009;376:153–160.
   PubMed Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 2008;361:104–111.
   PubMed Web of Science ®Google Scholar
• Abraham Lingan M, Abdul Hasan Sathali A, Vijaya Kumar MR, Gokila A. Formulation and evaluation of topical drug delivery system containing clobetasol propionate niosomes. Sci Rev Chem Commun 2011;1:7–17.
   Google Scholar
• Kamboj S, Saina V, Bala S. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. Sci World J 2014;2014:959741.
   Web of Science ®Google Scholar
• Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 2010;99:2049–2060.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Pardakhtya A, Hajihashemi V, Najafabadi AR. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv 2003;10:251–262.
   PubMed Web of Science ®Google Scholar
• Namedeo A, Jain NK. Niosomal delivery of 5-flurouracil. J Microencapsul 1999;16:731–740.
   PubMed Web of Science ®Google Scholar
• Abdallah M, Sammour O, EL-Ghamry H, Abu-Selem M. Preparation and in-vitro evaluation of diclofenac sodium niosomal formulations. Int J Pharm Sci Res 2013;4:1757–1765.
   Google Scholar
• Patidar S, Jain S. Non ionic surfactant based vesicles (niosomes) containing flupirtine maleate as an ocular drug delivery system. J Chem Pharm Res 2014;4:4495–4500.
   Google Scholar
• Abu Hashim II, El-Dahan MS, Yousif RM, et al. potential use of niosomal hydrogel as an ocular delivery system of atenolol. Biol Pharm Bull 2014;37:541–551.
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998;172:33–70.
   Web of Science ®Google Scholar
• Mansour M, Mansour S, Mortada ND, Abdelhady SS. Ocular poloxamer based ciprofloxacin hydrochloride in situ forming gels. Drug Dev Ind Pharm 2008;34:744–752.
   PubMed Web of Science ®Google Scholar
• Akbari V, Sadeghi-Aliabadi H. Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation. J Nanopart Res 2013;15:1–14.
   Web of Science ®Google Scholar
• Gubernator J, Doroszkiewicz W, Drulis-Kawa Z, et al. In-vitro antimicrobial activity of liposomes containing ciprofloxacin, meropenem and gentamicin against Gram-negative clinical bacterial strains. Lett Drug Des Discov 2007;4:297–304.
   Web of Science ®Google Scholar